1556
G. L. Huang, Y. P. Dai
LETTER
O
BTC, Ph3P
O
OH
Cl
Cl
=
Wang resin
Wang-chlorinated resin 7
Scheme 4 Preparation of Wang-chlorinated resin 7
OBn
N
OBn
The diol 8 (Scheme 5) was prepared with the approach
that described by Griffith and Danishefsky.11 The C-3 hy-
droxy group of compound 8 was selectively benzylated by
the way of stannylene methodology5 to provide the diben-
zylated building block 6 in 45% yield. Glycosylation re-
actions were performed using 3.0 equivalents of donor
and 1.2 equivalents of trimethylsilyl trifluoromethane-
sulfonate (TMSOTf) as promoter for the activation of tri-
chloroacetimidate donor. At low temperature, TMSOTf-
promoted glycosylation of the trichloroacetimidate donor
5 with the 6-O-benzylallosamizoline alcohol acceptor 6
gave the corresponding b-pseudodisaccharide 19 in 68%
yield. The yield was analyzed by HPLC after cleavage of
Wang resin with trifluoroacetic acid from building block
19. Cleavage of the levulinoyl ester was performed using
hydrazine acetate dissolved in MeOH to obtain the accep-
tor 4.12 After the acceptor 4 was glycosylated with the do-
nor 3, resin was washed, filtered, and dried under the
vacuum overnight. The saccharide-bound resin was cata-
lytically hydrogenated to cleave the Cbz, Wang resin, and
Bn (90% yield). Then, the resulting mixture was acetylat-
ed with Ac2O/pyridine and deacetylated with NaOMe/
MeOH, respectively, to obtain a crude product. The crude
product was purified by size-exclusion chromatography
on Biogel P4 to afford the corresponding target pseudot-
risaccharide 113 in 71% yield for the last three steps.
HO
Bu2SnO
O
HO
HO
O
O
NMe2
7, CsF
N
NMe2
LevO
6
8
TMSOTf
5,
OBn
O
OBn
N
O
O
O
NMe2
NHCbz
AcO
19
N2H4⋅HOAc
OBn
O
OBn
HO
O
O
O
N
NMe2
NHCbz
AcO
4
a. 3, TMSOTf
b. H2, Pd/C
c. Ac2O, pyridine
d. NaOMe, MeOH
OH
O
OH
O
O
OH
HO
O
O
HO
NHAc
HO
N
NMe2
NHAc
HO
1
In summary, the solid-phase synthesis of allosamidin 1
with NHCbz-protected allosamine donors has been stud-
ied. With Wang resin, good yields were obtained through-
out the iterative assemblies.
Scheme 5 Solid-phase synthesis of allosamidin 1
(7) DeNinno, M. P.; Etienne, J. B.; Duplantier, K. C.
Tetrahedron Lett. 1995, 36, 669.
(8) Melean, L. G.; Love, K. R.; Seeberger, P. H. Carbohydr.
Res. 2002, 337, 1893.
(9) Corey, E. J.; Venkateswarlu, A. J. Am. Chem. Soc. 1972, 94,
6190.
(10) Rivero, I. A.; Somanathan, R.; Hellberg, L. H. Synth.
Commun. 1993, 23, 711.
Acknowledgment
This work was supported by Natural Science Foundation Project of
CQ CSTC (No. CSTC, 2009BB5238), China.
(11) Griffith, D. A.; Danishefsky, S. J. J. Am. Chem. Soc. 1991,
113, 5863.
(12) Reichardt, N.-C.; Martin-Lomas, M. Angew. Chem. Int. Ed.
2003, 42, 4674.
(13) Allosamidin 1
References and Notes
(1) Sakuda, S.; Isogai, A.; Matsumoto, S.; Suzuki, A. J. Anibiot.
1987, 40, 296.
(2) Berecibar, A.; Grandjean, C.; Siriwardena, A. Chem. Rev.
IR (KBr): 3500, 3365, 1652, 1550, 1060 cm–1. 1H NMR (300
MHz, D2O): d = 5.37 (dd, 1 H, H-1), 4.80 (d, 1 H, H-1¢¢), 4.78
(d, 1 H, H-1¢), 4.37 (dd, 1 H, H-2), 4.36 (t, 1 H, H-3¢), 4.30
(t, 1 H, H-3), 4.07 (t, 1 H, H-3¢¢), 3.92–2.66 (m, 12 H), 3.61
(dd, 1 H, H-6¢), 3.09–3.08 [d, 6 H, N(CH3)2], 3.67–3.63 (m,
1 H, H-5), 2.09–2.07 (d, 6 H, 2 × NHCOCH3). 13C NMR (75
MHz, D2O): d = 174.03, 173.79, 160.61, 100.58, 99.92,
86.79, 85.01, 80.48, 76.90, 73.63, 72.59, 70.11, 68.95,
66.40, 64.18, 60.97, 60.84, 59.20, 53.01, 52.63, 51.42,
37.60, 37.41, 22.05. ESI-MS: m/z = 645.2 [M + Na]+.
1999, 99, 779.
(3) (a) Tanaka, K.; Fujimoto, Y.; Tanaka, S.; Mori, Y.; Fukase,
K. In Glycoscience, Part 5; Fraser-Reid, B.; Tatsuta, K.;
Thiem, J., Eds.; Springer: Berlin/Heidelberg, 2008, 1205.
(b) Plante, O. J.; Palmacci, E. R.; Seeberger, P. H. Science
2001, 291, 1523.
(4) Manabe, S.; Ito, Y. Chem. Pharm. Bull. 2001, 49, 1234.
(5) Watanabe, Y.; Kiyosawa, Y.; Hyodo, S.; Hayashi, M.
Tetrahedron Lett. 2005, 46, 281.
(6) Jeanloz, R. W. J. Am. Chem. Soc. 1957, 79, 2591.
Synlett 2010, No. 10, 1554–1556 © Thieme Stuttgart · New York